Epigenetics and Human Disease Laboratory, Faro, Portugal.
Department of Biomedical Sciences and Medicine, Faro, Portugal.
Adv Ther. 2020 Jun;37(6):2667-2677. doi: 10.1007/s12325-020-01348-4. Epub 2020 Apr 23.
During the last 60 years numerous significant attempts have been made to achieve a widely acceptable terminology and histological grading for laryngeal squamous intraepithelial lesions. While dysplasia was included in the pathology of the uterine cervix already in 1953, the term dysplasia was accepted in laryngeal pathology first after the Toronto Centennial Conference on Laryngeal Cancer in 1974. In 1963 Kleinsasser proposed a three-tier classification, and in 1971 Kambic and Lenart proposed a four-tier classification. Since then, four editions of the World Health Organisation (WHO) classification have been proposed (1978, 1991, 2005 and 2017). Several terms such as squamous intraepithelial neoplasia (SIN) and laryngeal intraepithelial neoplasia (LIN) are now being abandoned and replaced by squamous intraepithelial lesions (SIL). The essential change between the 2005 and 2017 WHO classifications is the attempt to induce a simplification from a four- to a two-tier system. The current WHO classification (2017) thus recommends the use of a two-tier system with reasonably clear histopathological criteria for the two groups: low-grade and high-grade dysplasia. Problems with interobserver variability apart, subjectivities and uncertainties remain, but to a lesser degree. Ongoing and additional molecular studies may help to clarify underlying events that will increase our understanding and possibly can facilitate our attempts to obtain an even better classification. The classification needs to be easier for the general pathologist to perform and easier for the clinician to interpret. These two objectives are equally important to provide each patient the best personalised treatment available for squamous intraepithelial lesions.
在过去的 60 年中,人们做出了无数次努力,试图为喉鳞状上皮内病变制定一种广泛接受的术语和组织学分级。虽然早在 1953 年,宫颈病变中就包括了不典型增生,但直到 1974 年多伦多百年喉癌会议后,不典型增生一词才被引入喉病理学。1963 年,克莱因萨瑟提出了三级分类法,1971 年,坎比奇和莱纳特提出了四级分类法。此后,世界卫生组织(WHO)提出了四版分类法(1978 年、1991 年、2005 年和 2017 年)。现在,一些术语如鳞状上皮内肿瘤(SIN)和喉上皮内肿瘤(LIN)已被弃用,代之以鳞状上皮内病变(SIL)。2005 年和 2017 年 WHO 分类之间的主要区别在于试图将四级系统简化为两级系统。目前的 WHO 分类(2017 年)因此建议使用两级系统,对于两组具有合理明确的组织病理学标准:低级别和高级别不典型增生。除了观察者间变异性问题外,主观性和不确定性仍然存在,但程度较轻。正在进行的和额外的分子研究可能有助于阐明潜在事件,从而提高我们的认识,并可能有助于我们更好地进行分类。分类需要更便于普通病理学家进行,也更便于临床医生解释。这两个目标同样重要,都是为了为每个患有鳞状上皮内病变的患者提供最佳的个性化治疗。